SPI
19.199,48
PKT
+147,96
PKT
+0,78
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.26 | UBS Buy | Deutsche Bank AG | |
| 10.02.26 | ams-OSRAM Buy | UBS AG | |
| 10.02.26 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 10.02.26 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 10.02.26 | ams-OSRAM Equal Weight | Barclays Capital | |
| 10.02.26 | UBS Outperform | RBC Capital Markets | |
| 10.02.26 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 10.02.26 | Roche Overweight | Barclays Capital | |
| 09.02.26 | Novartis Halten | DZ BANK | |
| 09.02.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 09.02.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.26 | Roche Overweight | Barclays Capital | |
| 06.02.26 | UBS Underweight | Barclays Capital | |
| 06.02.26 | Novartis Neutral | UBS AG | |
| 06.02.26 | UBS Neutral | Goldman Sachs Group Inc. | |
| 06.02.26 | ams-OSRAM Buy | UBS AG | |
| 06.02.26 | Nestlé Neutral | UBS AG | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | UBS Buy | Deutsche Bank AG | |
| 05.02.26 | Novartis Buy | Deutsche Bank AG | |
| 05.02.26 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.02.26 | Givaudan Halten | DZ BANK | |
| 04.02.26 | UBS Buy | Jefferies & Company Inc. | |
| 04.02.26 | UBS Outperform | RBC Capital Markets | |
| 04.02.26 | Novartis Neutral | UBS AG | |
| 04.02.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 04.02.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 04.02.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 04.02.26 | UBS Underweight | Barclays Capital | |
| 04.02.26 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 04.02.26 | Novartis Hold | Jefferies & Company Inc. | |
| 04.02.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.26 | UBS Buy | Goldman Sachs Group Inc. | |
| 02.02.26 | Roche Hold | Deutsche Bank AG | |
| 02.02.26 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 02.02.26 | Roche Kaufen | DZ BANK | |
| 02.02.26 | Roche Underperform | Jefferies & Company Inc. | |
| 30.01.26 | Roche Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 30.01.26 | Givaudan Neutral | UBS AG |